Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial.
Yohei SotomiKen KozumaKosuke KashiwabaraYoshiharu HiguchiKenji AndoYoshihiro MorinoJunya AkoKengo TanabeTakashi MuramatsuGaku NakazawaShungo HikosoYasushi Sakatanull nullPublished in: BMJ open (2021)
Japan Registry of Clinical Trials: jRCTs051190053; Pre-results.
Keyphrases
- atrial fibrillation
- study protocol
- clinical trial
- percutaneous coronary intervention
- oral anticoagulants
- st segment elevation myocardial infarction
- phase ii
- catheter ablation
- randomized controlled trial
- st elevation myocardial infarction
- acute myocardial infarction
- left atrial
- antiplatelet therapy
- open label
- left atrial appendage
- direct oral anticoagulants
- phase iii
- coronary artery bypass grafting
- double blind
- heart failure
- acute coronary syndrome
- coronary artery disease
- coronary artery bypass